Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF

Human Gene Therapy

Volumn 7, Issue 7, 1996, Pages 851-860

  Pochon, N A M ^a   Heyd, B ^a   Deglon N ^a   Joseph, J M ^a   Zurn, A D ^a   Baetge, E E ^b   Hammang, J P ^b   Goddard, M ^b   Lysaght, M ^b   Kaplan, F ^b   Kato, A C ^c   Schluep, M ^a   Hirt, L ^a   Regli, F ^a   Porchet, F ^a   De Tribolet, N ^a   Aebischer, P ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b CytoTherapeutics Inc   (United States)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GANCICLOVIR; NEUROTROPHIC FACTOR; THYMIDINE KINASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; ASTHENIA; CLINICAL PROTOCOL; CLINICAL TRIAL; COUGHING; DNA TRANSFECTION; DRUG SENSITIVITY; ENCAPSULATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; NONHUMAN; PATIENT SELECTION; PROTEIN EXPRESSION; RAT; RECOMBINANT GENE; STOMATITIS; WEIGHT REDUCTION;

EID: 19144369706     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.7-851     Document Type: Article

References (35)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H, Rahmani Z, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
2. Brown RHJ. Amyotrophic Lateral Sclerosis: recent insight from genetic and transgenic mice. Cell 1995; 80: 687-692.
3. Martinou J, Martinou I, Kato AC. Cholinergic differentiation factor promotes survival of isolated rat embryonic motoneurons in vitro. Neuron 1992; 8: 737-744.
4. Magal E, Burnham P, Varon S. Effects of ciliary neurotrophic factor on rat spinal cord neurons in vitro: survival and expression of choline acetyltransferase and low-affinity nerve growth factor receptors. Dev Brain Res 1991; 63: 141-150.
5. Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P. Glial cell line-derived neurotrophic fcator (GDNF), a new trophic factor for motoneurons. Neuroreport 1994; 6: 113-118.
6. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo M, Rullamas J, Evans T, McMahon SB, Armanini MP, Berkermeier L, Phillips HS, Rosenthal A. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993; 363: 266-270.
7. Henderson CE, Phillips HS, Pollack RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A. GDNF: A potent survival factor for motoneurons present in peripheral nerve muscle. Science 1994; 266: 1062-1064.
8. Hughes RA, Sendtner M, Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 1993; 36: 663-671.
9. Kato AC, Lindsay RM. Overlapping and additive effects of neurotrophins and CNTF on cultured human spinal cord neurons. Exp Neurol 1994; 130: 196-201.
10. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of neurons after axotomy. Nature 1990; 345: 440-441.
11. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde Y. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after sciatic nerve section. Nature 1992; 360: 757-759.
12. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360: 753-755.
13. Yan Q, Matheson C, Lopez OT. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 1995; 373: 341-344.
14. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 1992; 358: 502-504.
15. Aebischer P, Winn SR, Tresco PA, Greene LA, Jaeger CB. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. J Biomech Eng 1991; 113: 178-183.
16. Aebischer P, Winn SR, Tresco PA, Greene LA, Jaeger CB. Long term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line. Exp Neurol 1991; 3: 269-275.
17. Tresco PA, Winn SR, Tan S, Jaeger CB, Greene LA, Aebischer P. Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transpl 1992; 1: 255-264.
18. Aebischer P, Goddard M, Signore A, Timpson R. Functional recovery in hemiparkinsonian primates transplanted with polymer encapsulated PC12 cells. Exp Neurol 1994; 126: 151-158.
19. Hoffman D, Breakfield XO, Short P, Greene LA, Aebischer P. Transplantation of polymer encapsulated cells genetically engineered to release NGF. Exp Neurol 1993; 122: 100-106.
20. Kordower JH, Winn SR, Liu YT, Mufson EJ, Sladek JR Jr, Hammang JP, Baetge EE, Emerich DF. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 10898-10902.
21. Aebischer P, Buchser E, Joseph JM, Favre J, de Tribolet N, Lysaght M, Rudnick S, Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation 1994; 58: 1275-1277.
22. Sagen J, Wang H, Tresco PA, Aebischer P. Transplants of immunologically-isolated xenogeneic chromaffin cells provide a long-term source of pain reducing neuroactive substances. J Neurosci 1993; 13: 2415-2423.
23. Joseph JM, Goddard M, Mills J, Padrun V, Zurn A, Zielinski B, Favre J, Gardaz JP, Mosimann F, Sagen J, Christenson L, Aebischer P. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transpl 1994; 3: 355-364.
24. Baetge EB, Suh YH, Joh TH. Complete nucleotide and deduce amino acid sequence of bovine phenylethanolamine N-methyltransferase: partial amino acid homology with rat tyrosine hydroxylase. Proc Natl Acad Sci USA 1986; 83: 5454-5458.
25. Tan S, Déglon N, Baetge E, Zurn AD, Aebischer P. Rescue of motoneurons from axotomy induced cell death from polymer encapsulated cell genetically engeineered to release CNTF. Submitted.
26. Schmalbruch H, Jensen HS, Bjaerg M, Kamieniecka Z, Kurland L. A new mouse mutant with progressive motor neuronopathy. J Neuropath Exp Neurol 1991; 50:192-204.
27. Sagot Y, Tan S, Beatge E, Schmalbruch H, Kato AC, Aebischer P. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuropathy in the mouse. Eur J Neurosci 1995; 7: 1313-1322.
28. Yan Q, Matheson C, Lopez OT, Miller JA. The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor. J Neurosci 1994; 14: 5281-5291.
29. Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology 1988; 38: 405-408.
30. Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau LM. The natural history of motoneurons loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409-413.
31. Uldry C, Fitting J. Maximal values of the sniff nasal inspiratory pressure in healthy subjects. Thorax 1995; 50: 371-375.
32. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192: 540-542.
33. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 61-65.
34. Norris FH, Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721-728.
35. Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle & Nerve 1989; 12: 833-841.